Which has the lower trailing P/E, CI or GSK?

CI has the lower trailing P/E: CI trades at 11.52 and GSK at 16.49. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CI or GSK?

Over the past five years, CI grew revenue faster — CI at a 11.11% CAGR versus GSK at 1.38%.

Does CI or GSK pay a bigger dividend?

CI yields 2.21% and GSK yields 3.44% based on trailing dividends and the latest price.

Is CI or GSK more profitable?

GSK runs the higher net margin — CI at 2.27% versus GSK at 14.52%.

How have CI and GSK total returns compared?

Over the past 10 years, CI delivered 9.21% and GSK delivered 6.47% annualized total return. Past performance doesn't predict future results.

Cigna Corporation (CI) vs GSK plc (GSK)

A side-by-side comparison of Cigna Corporation and GSK plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 11, 2026. Differences are shown without an overall score or investment verdict.

Cigna Corporation

$72.37B

$273.87HealthcareDelayed quote: Aug 11, 2026, 4:00 PM EDT

GSK

GSK plc

$101.98B

$50.90HealthcareDelayed quote: Aug 11, 2026, 4:00 PM EDT

Total return — CI vs GSK

growth of $100 · dividends reinvested · last 10y

CI +132.8% (+8.8%/yr)GSK +88.1% (+6.5%/yr)CI compounded faster over this window

CI GSK

CI vs GSK: by the numbers

•GSK is the larger company ($101.98B vs $72.37B market cap).
•CI trades at the lower trailing earnings multiple (11.52 vs 16.49 P/E), one valuation lens rather than an overall verdict.
•GSK converts more revenue to profit (14.52% vs 2.27% net margin).
•CI grew revenue faster over the past five years (11.11% vs 1.38% CAGR).
•GSK pays the higher dividend yield (3.44% vs 2.21%).

Metrics side by side

Valuation

Metric	CI	GSK
P/E ratio	11.52	16.49
Forward P/E	9.14	14.58
P/S ratio	0.26	2.39
P/B ratio	1.72	4.56
EV / EBITDA	8.03	8.46
FCF yield	12.41%	8.80%

Profitability

Metric	CI	GSK
Gross margin	11.66%	72.71%
Operating margin	3.46%	20.72%
Net margin	2.27%	14.52%
ROE	15.05%	27.67%
ROIC	7.35%	16.61%

Dividends

Metric	CI	GSK
Dividend yield	2.21%	3.44%
Payout ratio	27.53%	47.32%

Growth (annualized)

Metric	CI	GSK
Revenue CAGR (5Y)	11.11%	1.38%
EPS CAGR (5Y)	-0.76%	-0.71%
FCF CAGR (5Y)	-1.95%	-2.45%
Total return CAGR (5Y)	7.67%	9.56%

Frequently asked

Which has the lower trailing P/E, CI or GSK?: CI has the lower trailing P/E: CI trades at 11.52 and GSK at 16.49. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CI or GSK?: Over the past five years, CI grew revenue faster — CI at a 11.11% CAGR versus GSK at 1.38%.
Does CI or GSK pay a bigger dividend?: CI yields 2.21% and GSK yields 3.44% based on trailing dividends and the latest price.
Is CI or GSK more profitable?: GSK runs the higher net margin — CI at 2.27% versus GSK at 14.52%.
How have CI and GSK total returns compared?: Over the past 10 years, CI delivered 9.21% and GSK delivered 6.47% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CI analysis Full GSK analysis Interactive comparison tool

Dig into the metrics

Cigna P/E ratio GSK P/E ratio Cigna dividend yield GSK dividend yield Cigna ROE GSK ROE Cigna operating margin GSK operating margin Cigna revenue growth GSK revenue growth Cigna free cash flow GSK free cash flow

Cigna & GSK appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 11, 2026.